Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
– FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million – – Q4 2025 U.S. Net Product Revenue Grew ~38% Y/Y to $43.7 Million; Q4 2025 Total...
-
Consumer research report examines TrimRx telehealth GLP-1 programs, compounded semaglutide and tirzepatide pricing, access and safety in 2026
-
2026 report on Direct Meds' compounded semaglutide and tirzepatide GLP-1 program, including pricing, telehealth process, and delivery formats.
-
Slim Force BHB ketone claims evaluated: 2026 consumer research report on ingredients, dosage research, pricing, and buyer verification.
-
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that its Board of Directors authorized a stock repurchase program of up to $100 million of the...
-
TMates GLP-1 claims evaluated: compounded semaglutide, tirzepatide telehealth access, pricing, provider structure, and consumer verification.
-
2026 consumer research report examining VisiFlora's 22-ingredient gut-eye axis formula, ingredient research context, and verification guidance.
-
Cambridge, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- In the last year, energy costs rose at triple the rate of overall inflation, the latest spike in a decades-long trend that has seen utility bills...
-
VIENNA, March 09, 2026 (GLOBE NEWSWIRE) -- Atlas today announced the launch of its multi-agent AI system within Atlas AI Studio, introducing AI agents capable of building and operating complete 3D...
-
MANCHESTER, N.H., March 09, 2026 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced broad national availability of its...